Basit öğe kaydını göster

dc.contributor.advisorŞimşek Kiper, Pelin Özlem
dc.contributor.authorAlkan, Dorukcan
dc.date.accessioned2023-03-08T08:47:51Z
dc.date.issued2022
dc.date.submitted2022-11-24
dc.identifier.citation1. Korlimarla A, Spiridigliozzi GA. Down Syndrome. Carey JC, Cassidy SB, Battaglia A, Viskochil D, editors. Cassidy and Allanson's Management of Genetic Syndromes. 4th edition. Hoboken: John Wiley & Sons Inc. ; 2021. 2. John Langdon Down 2016, Observations on an Ethnic Classification of Idiots by J. Langdon H. Down, M.D., London, London Hospital Reports, 3:259-262, 1866 3. Neri G, Opitz JM. Down syndrome: comments and reflections on the 50th anniversary of Lejeune's discovery. Am J Med Genet A. 2009 Dec;149A(12):2647-54. doi: 10.1002/ajmg.a.33138. PMID: 19921741. 4. Cassidy LM, Maoldúin RÓ, Kador T, Lynch A, Jones C, Woodman PC, Murphy E, Ramsey G, Dowd M, Noonan A, Campbell C, Jones ER, Mattiangeli V, Bradley DG. A dynastic elite in monumental Neolithic society. Nature. 2020 Jun;582(7812):384-388. doi: 10.1038/s41586-020-2378-6. Epub 2020 Jun 17. PMID: 32555485; PMCID: PMC7116870. 5. Wright D. Downs: the history of a disability. New York: Oxford University Press Inc. ; 2011 6. Ataman AD, Vatanoğlu-Lutz EE, Yıldırım G. Medicine in stamps: history of Down syndrome through philately. J Turk Ger Gynecol Assoc. 2012 Dec 1;13(4):267-9. doi: 10.5152/jtgga.2012.43. PMID: 24592054; PMCID: PMC3881714. 7. Bull MJ. Down Syndrome. N Engl J Med. 2020 Jun 11;382(24):2344-2352. doi: 10.1056/NEJMra1706537. PMID: 32521135. 8. Canadian Down Syndrome Society. About down syndrome [Internet]. No Date. [Erişim tarihi 10 Kasım 2022]. https://www.cdss.ca/resources/general-information 9. The Down Syndrome Medical Interest Group. Demography [Internet]. No Date. [Erişim tarihi 10 Kasım 2022]. https://www.dsmig.org.uk/information-resources/by-topic/demography/ 10. Down Syndrome Australia. Down syndrome statistics in Australia [Internet]. No Date. [Erişim tarihi 10 Kasım 2022]. https://www.downsyndrome.org.au/about-down-syndrome/statistics/# 11. New Zealand Down Syndrome Association. What is Down syndrome [Internet]. No Date. [Erişim tarihi 10 Kasım 2022]. https://www.nzdsa.org.nz/what-is-ds/ 12. Nussbaum RL, McInnes RR, Willard HF, Hamosh A. Thompson & Thompson genetics in medicine. 8th edition. Philadelphia: Elsevier Inc. ; 2016. 13. Jones KL, Jones MC, (Author), Del Campo M. Smith's recognizable patterns of human malformation: expert consult. 7th edition Philadelphia: Elsevier Inc. ; 2013. 14. Stoll C, Dott B, Alembik Y, Roth MP. Associated congenital anomalies among cases with Down syndrome. Eur J Med Genet. 2015 Dec;58(12):674-80. doi: 10.1016/j.ejmg.2015.11.003. Epub 2015 Nov 11. PMID: 26578241. 15. Rohit M, Shrivastava S. Acyanotic and Cyanotic Congenital Heart Diseases. Indian J Pediatr. 2018 Jun;85(6):454-460. doi: 10.1007/s12098-017-2454-6. Epub 2017 Sep 30. PMID: 28963608. 16. Bailliard, F., Anderson, R.H. Tetralogy of Fallot. Orphanet J Rare Dis 4, 2 (2009). https://doi.org/10.1186/1750-1172-4-2 17. Versacci P, Di Carlo D, Digilio MC, Marino B. Cardiovascular disease in Down syndrome. Curr Opin Pediatr. 2018 Oct;30(5):616-622. doi: 10.1097/MOP.0000000000000661. PMID: 30015688. 18. Kupferman JC, Druschel CM, Kupchik GS. Increased prevalence of renal and urinary tract anomalies in children with Down syndrome. Pediatrics. 2009 Oct;124(4):e615-21. doi: 10.1542/peds.2009-0181. Epub 2009 Sep 14. PMID: 19752083. 19. Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol. 2011 Apr;164(1):9-16. doi: 10.1111/j.1365-2249.2011.04335.x. Epub 2011 Feb 24. PMID: 21352207; PMCID: PMC3074212. 20. Santoro SL, Chicoine B, Jasien JM, Kim JL, Stephens M, Bulova P, Capone G. Pneumonia and respiratory infections in Down syndrome: A scoping review of the literature. Am J Med Genet A. 2021 Jan;185(1):286-299. doi: 10.1002/ajmg.a.61924. Epub 2020 Oct 19. PMID: 33073471. 21. Rodrigues M, Nunes J, Figueiredo S, Martins de Campos A, Geraldo AF. Neuroimaging assessment in Down syndrome: a pictorial review. Insights Imaging. 2019 May 20;10(1):52. doi: 10.1186/s13244-019-0729-3. PMID: 31111268; PMCID: PMC6527671. 22. Kreicher KL, Weir FW, Nguyen SA, Meyer TA. Characteristics and Progression of Hearing Loss in Children with Down Syndrome. J Pediatr. 2018 Feb;193:27-33.e2. doi: 10.1016/j.jpeds.2017.09.053. Epub 2017 Nov 22. PMID: 29174076. 23. Ugurlu A, Altinkurt E. Ophthalmologic Manifestations and Retinal Findings in Children with Down Syndrome. J Ophthalmol. 2020 Feb 7;2020:9726261. doi: 10.1155/2020/9726261. PMID: 32089873; PMCID: PMC7029299. 24. Rachel Whooten, MD, Jessica Schmitt, MD and Alison Schwartz, MD Curr Opin Endocrinol Diabetes Obes. 2018 February; 25(1): 61–66. doi:10.1097/MED. 0000000000000382. 25. Sakadamis A, Angelopoulou N, Matziari C, Papameletiou V, Souftas V. Bone mass, gonadal function and biochemical assessment in young men with trisomy 21. Eur J Obstet Gynecol Reprod Biol. 2002 Jan 10;100(2):208-12. doi: 10.1016/s0301-2115(01)00478-x. PMID: 11750967. 26. Angelopoulou N, Souftas V, Sakadamis A, Matziari C, Papameletiou V, Mandroukas K. Gonadal function in young women with Down syndrome. Int J Gynaecol Obstet. 1999 Oct;67(1):15-21. doi: 10.1016/s0020-7292(99)00123-x. PMID: 10576235. 27. Amr NH. Thyroid Disorders in Subjects with Down Syndrome: An Update. Acta Biomed. 2018 Mar 27;89(1):132-139. doi: 10.23750/abm.v89i1.7120. PMID: 29633736; PMCID: PMC6357620. 28. DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018 Jun 16;391(10138):2449-2462. doi: 10.1016/S0140-6736(18)31320-5. PMID: 29916386; PMCID: PMC6661119 29. Mortimer, G.L., Gillespie, K.M. Early Onset of Autoimmune Diabetes in Children with Down Syndrome—Two Separate Aetiologies or an Immune System Pre-Programmed for Autoimmunity?. Curr Diab Rep 20, 47 (2020). https://doi.org/10.1007/s11892-020-01318-8 30. Anil MA, Shabnam S, Narayanan S. Feeding and swallowing difficulties in children with Down syndrome. J Intellect Disabil Res. 2019 Aug;63(8):992-1014. doi: 10.1111/jir.12617. Epub 2019 Apr 4. PMID: 30950140. 31. Bermudez BEBV, de Oliveira CM, de Lima Cat MN, Magdalena NIR, Celli A. Gastrointestinal disorders in Down syndrome. Am J Med Genet A. 2019 Aug;179(8):1426-1431. doi: 10.1002/ajmg.a.61258. Epub 2019 Jun 10. PMID: 31183986. 32. Liu E, Wolter-Warmerdam K, Marmolejo J, Daniels D, Prince G, Hickey F. Routine Screening for Celiac Disease in Children With Down Syndrome Improves Case Finding. J Pediatr Gastroenterol Nutr. 2020 Aug;71(2):252-256. doi: 10.1097/MPG.0000000000002742. PMID: 32304557. 33. Ali FE, Al-Bustan MA, Al-Busairi WA, Al-Mulla FA, Esbaita EY. Cervical spine abnormalities associated with Down syndrome. Int Orthop. 2006 Aug;30(4):284-9. doi: 10.1007/s00264-005-0070-y. Epub 2006 Mar 7. PMID: 16525818; PMCID: PMC2532127. 34. Rosenbaum DM, Blumhagen JD, King HA. Atlantooccipital instability in Down syndrome. AJR Am J Roentgenol. 1986 Jun;146(6):1269-72. doi: 10.2214/ajr.146.6.1269. PMID: 2939701. 35. Li Z, Celestin J, Lockey RF. Pediatric Sleep Apnea Syndrome: An Update. J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):852-61. doi: 10.1016/j.jaip.2016.02.022. Epub 2016 Jun 30. PMID: 27372597. 36. Hizal M, Satırer O, Polat SE, Tural DA, Ozsezen B, Sunman B, Karahan S, Emiralioglu N, Simsek-Kiper PO, Utine GE, Boduroglu K, Yalcin E, Dogru D, Kiper N, Ozcelik U. Obstructive sleep apnea in children with Down syndrome: is it possible to predict severe apnea? Eur J Pediatr. 2022 Feb;181(2):735-743. doi: 10.1007/s00431-021-04267-w. Epub 2021 Sep 25. PMID: 34562164; PMCID: PMC8475480. 37. Gipson K, Lu M, Kinane TB. Sleep-Disordered Breathing in Children. Pediatr Rev. 2019 Jan;40(1):3-13. doi: 10.1542/pir.2018-0142. Erratum in: Pediatr Rev. 2019 May;40(5):261. PMID: 30600274; PMCID: PMC6557418. 38. Fan Z, Ahn M, Roth HL, Li L, Vaughn BV. Sleep Apnea and Hypoventilation in Patients with Down Syndrome: Analysis of 144 Polysomnogram Studies. Children (Basel). 2017 Jun 30;4(7):55. doi: 10.3390/children4070055. PMID: 28665356; PMCID: PMC5532547. 39. Lee CF, Lee CH, Hsueh WY, Lin MT, Kang KT. Prevalence of Obstructive Sleep Apnea in Children With Down Syndrome: A Meta-Analysis. J Clin Sleep Med. 2018 May 15;14(5):867-875. doi: 10.5664/jcsm.7126. PMID: 29734982; PMCID: PMC5940439. 40. Hart SJ, Zimmerman K, Linardic CM, Cannon S, Pastore A, Patsiogiannis V, Rossi P, Santoro SL, Skotko BG, Torres A, Valentini D, Vellody K, Worley G, Kishnani PS. Detection of iron deficiency in children with Down syndrome. Genet Med. 2020 Feb;22(2):317-325. doi: 10.1038/s41436-019-0637-4. Epub 2019 Aug 16. PMID: 31417190; PMCID: PMC8039980. 41. Lee P, Bhansali R, Izraeli S, Hijiya N, Crispino JD. The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome. Leukemia. 2016 Sep;30(9):1816-23. doi: 10.1038/leu.2016.164. Epub 2016 Jun 10. PMID: 27285583; PMCID: PMC5434972. 42. Bhatnagar N, Nizery L, Tunstall O, Vyas P, Roberts I. Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update. Curr Hematol Malig Rep. 2016 Oct;11(5):333-41. doi: 10.1007/s11899-016-0338-x. PMID: 27510823; PMCID: PMC5031718. 43. Onciu M. Acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009 Aug;23(4):655-74. doi: 10.1016/j.hoc.2009.04.009. PMID: 19577163. 44. Rubnitz JE, Gibson B, Smith FO. Acute myeloid leukemia. Hematol Oncol Clin North Am. 2010 Feb;24(1):35-63. doi: 10.1016/j.hoc.2009.11.008. PMID: 20113895. 45. Watanabe K. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome. Pediatr Int. 2019 Mar;61(3):222-229. doi: 10.1111/ped.13776. Epub 2019 Mar 4. PMID: 30593694. 46. Raveau M, Nakahari T, Asada S, Ishihara K, Amano K, Shimohata A, Sago H, Yamakawa K. Brain ventriculomegaly in Down syndrome mice is caused by Pcp4 dose-dependent cilia dysfunction. Hum Mol Genet. 2017 Mar 1;26(5):923-931. doi: 10.1093/hmg/ddx007. PMID: 28069794. 47. Movsas, T.Z., Spitzer, A.R. and Gewolb, I.H. (2016), Ventriculomegaly in very-low-birthweight infants with Down syndrome. Dev Med Child Neurol, 58: 1167-1171. https://doi.org/10.1111/dmcn.13191 48. Altuna,M.;Giménez,S.; Fortea, J. Epilepsy in Down Syndrome: A Highly Prevalent Comorbidity. J. Clin. Med. 2021, 10, 2776. https://doi.org/10.3390/ jcm10132776 49. Kurt Eggers, Sabine Van Eerdenbrugh, Speech disfluencies in children with Down Syndrome, Journal of Communication Disorders, Volume 71, 2018, Pages 72-84, ISSN 0021-9924, 50. Kurt Eggers, Sabine Van Eerdenbrugh,Speech disfluencies in children with Down Syndrome,Journal of Communication Disorders,Volume 71,2018,Pages 72-84,ISSN 0021-9924,https://doi.org/10.1016/j.jcomdis.2017.11.001 51. Tsao R, Moy E, Velay JL, Carvalho N, Tardif C. Handwriting in Children and Adults With Down Syndrome: Developmental Delay or Specific Features? Am J Intellect Dev Disabil. 2017 Jul;122(4):342-353. doi: 10.1352/1944-7558-122.4.342. Erratum in: Am J Intellect Dev Disabil. 2017 Nov;122(6):fmi. PMID: 28654414. 52. Rork, JF, McCormack, L, Lal, K, Wiss, K, Belazarian, L. Dermatologic conditions in Down syndrome: A single-center retrospective chart review. Pediatr Dermatol. 2020; 37: 811– 816. https://doi.org/10.1111/pde.14214 53. Rork, JF, McCormack, L, Lal, K, Wiss, K, Belazarian, L. Dermatologic conditions in Down syndrome: A single-center retrospective chart review. Pediatr Dermatol. 2020; 37: 811– 816. doi.org/10.1111/pde.14214 54. Schepis C, Barone C, Siragusa M, Pettinato R, Romano C. An updated survey on skin conditions in Down syndrome. Dermatology. 2002;205(3):234-8. doi: 10.1159/000065859. PMID: 12399669. 55. Madan, V., Williams, J. and Lear, J.T. (2006), Dermatological manifestations of Down's syndrome. Clinical and Experimental Dermatology, 31: 623-629. https://doi.org/10.1111/j.1365-2230.2006.02164.x 56. Foley C, Killeen OG. Arch Dis Child 2019;104:482–487. doi:10.1136/archdischild-2018-315751 57. Goud, E. V. Soma Sekhar1; Gulati, Saakshi2; Agrawal, Akriti3; Pani, Pooja4; Nishant, K5; Pattnaik, Samarjeet J.6; Gupta, Shivam7,. Implications of Down’s syndrome on oral health status in patients: A prevalence-based study. Journal of Family Medicine and Primary Care: November 2021 - Volume 10 - Issue 11 - p 4247-4252 doi: 10.4103/jfmpc.jfmpc_885_21 58. Bull MJ, Trotter T, Santoro SL, et al; AAP Council on Genetics. Health Supervision for Children and Adolescents With Down Syndrome. Pediatrics. 2022;149(5):e2022057010 59. Huang, T., Gibbons, C., Rashid, S. et al. Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies. BMC Pregnancy Childbirth 20, 713 (2020). https://doi.org/10.1186/s12884-020-03394-w 60. Sheets KB, Crissman BG, Feist CD, Sell SL, Johnson LR, Donahue KC, Masser-Frye D, Brookshire GS, Carre AM, Lagrave D, Brasington CK. Practice guidelines for communicating a prenatal or postnatal diagnosis of Down syndrome: recommendations of the national society of genetic counselors. J Genet Couns. 2011 Oct;20(5):432-41. doi: 10.1007/s10897-011-9375-8. Epub 2011 May 27. PMID: 21618060. 61. Kurtoğlu S, Hatipoğlu N, Mazıcıoğlu MM, Akın MA, Çoban D, Gökoğlu S, Baştuğ O. Body weight, length and head circumference at birth in a cohort of Turkish newborns. J Clin Res Pediatr Endocrinol. 2012 Sep;4(3):132-9. doi: 10.4274/jcrpe.693. Epub 2012 May 4. PMID: 22664362; PMCID: PMC3459161. 62. Classification of Congenital Abnormalities of the CNS 63. Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, Lung B, Kluin J, Lang IM, Meijboom F, Moons P, Mulder BJM, Oechslin E, Roos-Hesselink JW, Schwerzmann M, Sondergaard L, Zeppenfeld K; ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021 Feb 11;42(6):563-645. doi: 10.1093/eurheartj/ehaa554. PMID: 32860028. 64. Tezcan İ, Berkel Aİ, Ersoy F, Sanal Ö. Sağlıklı Türk çocukları ve erişkinlerde türbimetrik yöntemle bakılan serum immünglobülin düzeyleri. Çocuk Sağlığı ve Hastalıkları Dergisi 1996; 39: 649-656 65. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, Wara DW, Douglas SD, Luzuriaga K, McFarland EJ, Yogev R, Rathore MH, Levy W, Graham BL, Spector SA; Pediatric AIDS Clinical Trials Group. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003 Nov;112(5):973-80. doi: 10.1016/j.jaci.2003.07.003. PMID: 14610491). 66. Uludağ Üniversitesi Tıp Fakültesi Dergisi 33 (2) 61-64, 2007 67. Ayfer Çolak, Merve Zeytinli Akşit, Neşe Şimşek, Pınar Bilgi, Murat Anıl. Iron, Folate and Vitamin B12 Status of Children and Adolescents: Single Center Study in the Aegean Region. J Dr Behcet Uz Child Hosp. 2019; 9(3): 183-190 68. Stagi S, Lapi E, Romano S, Bargiacchi S, Brambilla A, Giglio S, Seminara S, de Martino M. Determinants of vitamin d levels in children and adolescents with down syndrome. Int J Endocrinol. 2015;2015:896758. doi: 10.1155/2015/896758. Epub 2015 Jan 20. PMID: 25685147; PMCID: PMC4320854. 69. Stoll C, Alembik Y, Dott B, Roth MP. Epidemiology of Down syndrome in 118,265 consecutive births. Am J Med Genet Suppl. 1990;7:79-83. doi: 10.1002/ajmg.1320370715. PMID: 2149980. 70. Morris JK, Cole TJ, Springett AL, Dennis J. Down syndrome birth weight in England and Wales: Implications for clinical practice. Am J Med Genet A. 2015 Dec;167A(12):3070-5. doi: 10.1002/ajmg.a.37366. Epub 2015 Sep 26. PMID: 26407756; PMCID: PMC4950055. 71. Boghossian NS, Horbar JD, Murray JC, Carpenter JH; Vermont Oxford Network. Anthropometric charts for infants with trisomies 21, 18, or 13 born between 22 weeks gestation and term: the VON charts. Am J Med Genet A. 2012 Feb;158A(2):322-32. doi: 10.1002/ajmg.a.34423. Epub 2012 Jan 13. PMID: 22246859; PMCID: PMC3646092. 72. Martin T, Smith A, Breatnach CR, Kent E, Shanahan I, Boyle M, Levy PT, Franklin O, El-Khuffash A. Infants Born with Down Syndrome: Burden of Disease in the Early Neonatal Period. J Pediatr. 2018 Feb;193:21-26. doi: 10.1016/j.jpeds.2017.09.046. Epub 2017 Nov 23. PMID: 29174996. 73. Koc E, Demirel N, Bas AY, Ulubas Isik D, Hirfanoglu IM, Tunc T, Sari FN, Karatekin G, Ozdemir R, Altunhan H, Cetinkaya M, Ozcan B, Ozkiraz S, Calkavur S, Tekgunduz KS, Tastekin A, Ozlu F, Mutlu Ozyurt B, Ozdemir A, Cetinkaya B, Demirelli Y, Koklu E, Celik U, Tarakci N, Armangil D, Okulu E, Narter F, Mutlu B, Mert MK, Bulbul A, Asker HS, Uygur O, Uslu IS, Ertugrul S, Aydemir C, Celik HT, Kucuktasci K, Arslan S, Ergin H, Zenciroglu A, Yurttutan S, Orman A, Tuncer O, Yasa B, Acunas B, Takci S, Gokmen Z, Ozkan H, Comert S, Ustun N, Mutlu M, Bayraktar BT, Bilgin L, Tuzun F, Aydemir O, Gursoy T, Akdag A, Memisoglu A, Can E, Terek D, Beken S, Turan O, Guzoglu N, Ors R, Kale Y, Hekimoglu B, Aylanc H, Eroglu F, Sahin S, Konak M, Sarici D, Kilic I, Hakan N. Early neonatal outcomes of very-low-birth-weight infants in Turkey: A prospective multicenter study of the Turkish Neonatal Society. PLoS One. 2019 Dec 18;14(12):e0226679. doi: 10.1371/journal.pone.0226679. PMID: 31851725; PMCID: PMC6919617. 74. Brock JK, Walsh JD, Allen VM. The Effect of Fetal Trisomy 21 on Adverse Perinatal Obstetrical Outcomes in Nova Scotia, 2000-2019. J Obstet Gynaecol Can. 2021 May;43(5):583-588. doi: 10.1016/j.jogc.2020.09.019. Epub 2020 Oct 6. PMID: 33229281. 75. Bahr TM, Henry E, Hulse W, Baer VL, Prchal JT, Bhutani VK, Christensen RD. Early Hyperbilirubinemia in Neonates with Down Syndrome. J Pediatr. 2020 Apr;219:140-145. doi: 10.1016/j.jpeds.2019.12.039. Epub 2020 Jan 31. PMID: 32014279. 76. Sayee R, Thomas IM. Consanguinity, non-disjunction, parental age and Down's syndrome. J Indian Med Assoc. 1998 Nov;96(11):335-7. PMID: 10218319. 77. Marilyn J. Bull, Tracy Trotter, Stephanie L. Santoro, Celanie Christensen, Randall W. Grout, THE COUNCIL ON GENETICS; Health Supervision for Children and Adolescents With Down Syndrome. Pediatrics May 2022; 149 (5): e2022057010. 10.1542/peds.2022-057010 78. Marilyn J. Bull, the Committee on Genetics; Health Supervision for Children With Down Syndrome. Pediatrics August 2011; 128 (2): 393–406. 10.1542/peds.2011-1605 79. O'Neill ME, Ryan A, Kwon S, Binns HJ. Evaluation of Pediatrician Adherence to the American Academy of Pediatrics Health Supervision Guidelines for Down Syndrome. Am J Intellect Dev Disabil. 2018 Sep;123(5):387-398. doi: 10.1352/1944-7558-123.5.387. PMID: 30198765. 80. Tubman TR, Shields MD, Craig BG, Mulholland HC, Nevin NC. Congenital heart disease in Down's syndrome: two year prospective early screening study. BMJ. 1991 Jun 15;302(6790):1425-7. doi: 10.1136/bmj.302.6790.1425. PMID: 1829969; PMCID: PMC1670107. 81. Frid C, Drott P, Lundell B, Rasmussen F, Annerén G. Mortality in Down's syndrome in relation to congenital malformations. J Intellect Disabil Res. 1999 Jun;43 ( Pt 3):234-41. doi: 10.1046/j.1365-2788.1999.00198.x. PMID: 10392609. 82. Freeman SB, Bean LH, Allen EG, Tinker SW, Locke AE, Druschel C, Hobbs CA, Romitti PA, Royle MH, Torfs CP, Dooley KJ, Sherman SL. Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genet Med. 2008 Mar;10(3):173-80. doi: 10.1097/GIM.0b013e3181634867. PMID: 18344706. 83. Ghmaird A, Alrashidi T, Alqahtani Y S, et al. (October 24, 2020) Types and Distribution of Congenital Heart Defects in Pediatric Patients with Down’s Syndrome: A Retrospective Study. Cureus 12(10): e11133. DOI 10.7759/cureus.11133 84. Dakkak W, Oliver TI. Ventricular Septal Defect. [Updated 2022 May 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan- 85. Alexander M, Petri H, Ding Y, Wandel C, Khwaja O, Foskett N. Morbidity and medication in a large population of individuals with Down syndrome compared to the general population. Dev Med Child Neurol. 2016 Mar;58(3):246-54. doi: 10.1111/dmcn.12868. Epub 2015 Aug 18. PMID: 26282180. 86. Mårild K, Stephansson O, Grahnquist L, Cnattingius S, Söderman G, Ludvigsson JF. Down syndrome is associated with elevated risk of celiac disease: a nationwide case-control study. J Pediatr. 2013 Jul;163(1):237-42. doi: 10.1016/j.jpeds.2012.12.087. Epub 2013 Feb 8. PMID: 23399451. 87. Boëchat MC, Silva KS, Llerena JC Jr, Boëchat PR. Cholelithiasis and biliary sludge in Downs syndrome patients. Sao Paulo Med J. 2007 Nov 1;125(6):329-32. doi: 10.1590/s1516-31802007000600005. PMID: 18317602. 88. Morton RE, Khan MA, Murray-Leslie C, Elliott S. Atlantoaxial instability in Down's syndrome: a five year follow up study. Arch Dis Child. 1995 Feb;72(2):115-8; discussion 118-9. doi: 10.1136/adc.72.2.115. PMID: 7702371; PMCID: PMC1511025. 89. Tu A, Melamed E, Krieger MD. Dynamic MRI in the Evaluation of Atlantoaxial Stability in Pediatric Down Syndrome Patients. Pediatr Neurosurg. 2019;54(1):12-20. doi: 10.1159/000495788. Epub 2019 Jan 24. PMID: 30677764. 90. Ghaith B, Al Halabi M, Khamis AH, Kowash M. Oral Health Status among Children with Down Syndrome in Dubai, United Arab Emirates. J Int Soc Prev Community Dent. 2019 May-Jun;9(3):232-239. doi: 10.4103/jispcd.JISPCD_396_18. Epub 2019 Jun 7. PMID: 31198694; PMCID: PMC6559046. 91. B Ozhan, H Evrengul, S Yılmaz Agladıoglu, Ümıt Yasar, S Demır, Vitamin D Status of Children in a University Hospitalin West Turkey, HK J Paediatr (new series) 2016;21:251-256 92. Dixon NE, Crissman BG, Smith PB, Zimmerman SA, Worley G, Kishnani PS. Prevalence of iron deficiency in children with Down syndrome. J Pediatr. 2010 Dec;157(6):967-971.e1. doi: 10.1016/j.jpeds.2010.06.011. Epub 2010 Jul 21. PMID: 20650467; PMCID: PMC2988945. 93. van der Merwe LF, Eussen SR. Iron status of young children in Europe. Am J Clin Nutr. 2017 Dec;106(Suppl 6):1663S-1671S. doi: 10.3945/ajcn.117.156018. Epub 2017 Oct 25. PMID: 29070549; PMCID: PMC5701725. 94. Rasmussen SA, Fernhoff PM, Scanlon KS. Vitamin B12 deficiency in children and adolescents. J Pediatr. 2001 Jan;138(1):10-7. doi: 10.1067/mpd.2001.112160. PMID: 11148506. 95. Wong E, Molina-Cruz R, Rose C, Bailey L, Kauwell GPA, Rosenthal J. Prevalence and Disparities in Folate and Vitamin B12 Deficiency Among Preschool Children in Guatemala. Matern Child Health J. 2022 Jan;26(1):156-167. doi: 10.1007/s10995-021-03257-6. Epub 2021 Oct 12. PMID: 34637065; PMCID: PMC8770614. 96. Jory J. Red cell folate status among a subset of Canadian children with Down Syndrome post-fortification. J Intellect Disabil Res. 2022 May;66(5):471-482. doi: 10.1111/jir.12925. Epub 2022 Mar 9. PMID: 35266234. 97. Ercis M, Balci S, Atakan N. Dermatological manifestations of 71 Down syndrome children admitted to a clinical genetics unit. Clin Genet. 1996 Nov;50(5):317-20. doi: 10.1111/j.1399-0004.1996.tb02381.x. PMID: 9007317. 98. Romano C, Tiné A, Fazio G, Rizzo R, Colognola RM, Sorge G, Bergonzi P, Pavone L. Seizures in patients with trisomy 21. Am J Med Genet Suppl. 1990;7:298-300. doi: 10.1002/ajmg.1320370758. PMID: 2149964. 99. Stafstrom CE, Patxot OF, Gilmore HE, Wisniewski KE. Seizures in children with Down syndrome: etiology, characteristics and outcome. Dev Med Child Neurol. 1991 Mar;33(3):191-200. doi: 10.1111/j.1469-8749.1991.tb05108.x. PMID: 1827417. 100. Goldberg-Stern H, Strawsburg RH, Patterson B, Hickey F, Bare M, Gadoth N, Degrauw TJ. Seizure frequency and characteristics in children with Down syndrome. Brain Dev. 2001 Oct;23(6):375-8. doi: 10.1016/s0387-7604(01)00239-x. PMID: 11578846. 101. O'Driscoll MC, Black GC, Clayton-Smith J, Sherr EH, Dobyns WB. Identification of genomic loci contributing to agenesis of the corpus callosum. Am J Med Genet A. 2010 Sep;152A(9):2145-59. doi: 10.1002/ajmg.a.33558. PMID: 20683985. 102. Sacco S, Bouis C, Gallard J, Pichot A, Blondiaux E, Marey I, Dorison N, Sturtz F, Cieuta-Walti C, Ravel A, Mircher C. Psychomotor development in infants and young children with Down syndrome-A prospective, repeated measure, post-hoc analysis. Am J Med Genet A. 2022 Mar;188(3):818-827. doi: 10.1002/ajmg.a.62587. Epub 2021 Dec 4. PMID: 34863019. 103. Malak R, Kostiukow A, Krawczyk-Wasielewska A, Mojs E, Samborski W. Delays in Motor Development in Children with Down Syndrome. Med Sci Monit. 2015 Jul 1;21:1904-10. doi: 10.12659/MSM.893377. PMID: 26132100; PMCID: PMC4500597. 104. Lukowski AF, Milojevich HM, Eales L. Cognitive Functioning in Children with Down Syndrome: Current Knowledge and Future Directions. Adv Child Dev Behav. 2019;56:257-289. doi: 10.1016/bs.acdb.2019.01.002. Epub 2019 Feb 21. PMID: 30846049. 105. Dykens EM, Shah B, Sagun J, Beck T, King BH. Maladaptive behaviour in children and adolescents with Down's syndrome. J Intellect Disabil Res. 2002 Sep;46(Pt 6):484-92. doi: 10.1046/j.1365-2788.2002.00431.x. PMID: 12354319. 106. Nightengale E, Yoon P, Wolter-Warmerdam K, Daniels D, Hickey F. Understanding Hearing and Hearing Loss in Children With Down Syndrome. Am J Audiol. 2017 Sep 18;26(3):301-308. doi: 10.1044/2017_AJA-17-0010. PMID: 28854301. 107. Maris M, Wojciechowski M, Van de Heyning P, Boudewyns A. A cross-sectional analysis of otitis media with effusion in children with Down syndrome. Eur J Pediatr. 2014 Oct;173(10):1319-25. doi: 10.1007/s00431-014-2323-5. Epub 2014 May 10. PMID: 24816633. 108. Barr E, Dungworth J, Hunter K, Mcfarlane M, Kubba H. The prevalence of ear, nose and throat disorders in preschool children with Down’s syndrome in Glasgow. Scottish Medical Journal. 2011;56(2):98-103. doi:10.1258/smj.2011.011036 109. Blake JM, Estrada Gomez D, Skotko BG, Torres A, Santoro SL. Pneumonia and respiratory infection in Down syndrome: A 10-year cohort analysis of inpatient and outpatient encounters across the lifespan. Am J Med Genet A. 2021 Oct;185(10):2878-2887. doi: 10.1002/ajmg.a.62355. Epub 2021 May 31. PMID: 34056836. 110. Neeraj Kumar Jat, D.K. Bhagwani, Namita Bhutani, Urvashi Sharma, Ram Sharma, Raju Gupta, Assessment of the prevalence of congenital heart disease in children with pneumonia in tertiary care hospital: A cross-sectional study, Annals of Medicine and Surgery, Volume 73, 2022, 103111, ISSN 2049-0801, https://doi.org/10.1016/j.amsu.2021.103111. 111. Ciftçi E, Güneş M, Köksal Y, Ince E, Doğru U. Underlying causes of recurrent pneumonia in Turkish children in a university hospital. J Trop Pediatr. 2003 Aug;49(4):212-5. doi: 10.1093/tropej/49.4.212. PMID: 12929881. 112. Hoving MF, Brand PL. Causes of recurrent pneumonia in children in a general hospital. J Paediatr Child Health. 2013 Mar;49(3):E208-12. doi: 10.1111/jpc.12114. Epub 2013 Feb 26. PMID: 23438187. 113. Owayed AF, Campbell DM, Wang EEL. Underlying Causes of Recurrent Pneumonia in Children. Arch Pediatr Adolesc Med. 2000;154(2):190–194. doi:10.1001/archpedi.154.2.190 114. R Lodha, M Puranik, UCM Natchu and SK Kabra Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India Acta Pediatr 91: 1170± 1173. 2002 115. Takeuchi S, Kitamura T, Ohbuchi T, Koizumi H, Takahashi R, Hohchi N, Suzuki H. Relationship between sleep apnea and thyroid function. Sleep Breath. 2015 Mar;19(1):85-9. doi: 10.1007/s11325-014-0966-0. Epub 2014 Mar 13. Erratum in: Sleep Breath. 2015 May;19(2):751. PMID: 24622960. 116. Bielicki P, Przybyłowski T, Kumor M, Barnaś M, Wiercioch M, Chazan R. Thyroid Hormone Levels and TSH Activity in Patients with Obstructive Sleep Apnea Syndrome. Adv Exp Med Biol. 2016;878:67-71. doi: 10.1007/5584_2015_180. PMID: 26542600. 117. Gozal D, Kheirandish-Gozal L, Capdevila OS, Dayyat E, Kheirandish E. Prevalence of recurrent otitis media in habitually snoring school-aged children. Sleep Med. 2008 Jul;9(5):549-54. doi: 10.1016/j.sleep.2007.08.002. Epub 2007 Oct 24. PMID: 17921061; PMCID: PMC2527176. 118. Alfred Dreher, MD (presenter); Martin Patscheider;Thomas Braun, Pediatric Obstructive Sleep Apnea and Otitis Media with Effusion, Otolaryngology–Head and Neck Surgery 145(2S) 119. Chien-Chia Huang, Pei-Wen Wu, Cheng-Hsun Chiu, Ta-Jen Lee, Chyi-Liang Chen, Assessment of sleep-disordered breathing in pediatric otitis media with effusion, Pediatrics & Neonatology, Volume 63, Issue 1, 2022, Pages 25-32, ISSN 1875-9572, https://doi.org/10.1016/j.pedneo.2021.06.013. 120. Martínez-Macías FJ, Bobadilla-Morales L, González-Cruz J, Quiles-Corona M, Corona-Rivera A, Peña-Padilla C, Orozco-Vela M, Silva-Cruz R, Velarde-Rivera F, Corona-Rivera JR. Descriptive study of the complete blood count in newborn infants with Down syndrome. Am J Med Genet A. 2017 Apr;173(4):897-904. doi: 10.1002/ajmg.a.38097. Epub 2017 Feb 7. PMID: 28168815. 121. García de la Puente, S., Flores-Arizmendi, K.A., Guerrero-Tapia, Y.Y. et al. Blood cytology in children with down syndrome. BMC Pediatr 22, 387 (2022). https://doi.org/10.1186/s12887-022-03450-8 122. Klusmann JH, Creutzig U, Zimmermann M, Dworzak M, Jorch N, Langebrake C, Pekrun A, Macakova-Reinhardt K, Reinhardt D. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood. 2008 Mar 15;111(6):2991-8. doi: 10.1182/blood-2007-10-118810. Epub 2008 Jan 8. PMID: 18182574; PMCID: PMC2265448. 123. Bhatnagar N, Nizery L, Tunstall O, Vyas P, Roberts I. Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update. Curr Hematol Malig Rep. 2016 Oct;11(5):333-41. doi: 10.1007/s11899-016-0338-x. PMID: 27510823; PMCID: PMC5031718. 124. Hill DA, Gridley G, Cnattingius S, et al. Mortality and Cancer Incidence Among Individuals With Down Syndrome. Arch Intern Med. 2003;163(6):705–711. doi:10.1001/archinte.163.6.705 125. Pierce MJ, LaFranchi SH, Pinter JD. Characterization of Thyroid Abnormalities in a Large Cohort of Children with Down Syndrome
. Horm Res Paediatr. 2017;87(3):170-178. doi: 10.1159/000457952. Epub 2017 Mar 3. PMID: 28259872; PMCID: PMC5483988. 126. Fort P, Lifshitz F, Bellisario R, Davis J, Lanes R, Pugliese M, Richman R, Post EM, David R. Abnormalities of thyroid function in infants with Down syndrome. J Pediatr. 1984 Apr;104(4):545-9. doi: 10.1016/s0022-3476(84)80544-2. PMID: 6231357.tr_TR
dc.identifier.urihttp://hdl.handle.net/11655/29454
dc.description.abstractAlkan, D. Evaluation of Clinical and Laboratory Findings of Individuals with Down Syndrome, 11 Years of Experience, Hacettepe University Faculty of Medicine, Department of Pediatrics, Thesis in Pediatrics, Ankara, 2022. Down syndrome occurs in 1 in 800 live births in the community and is the most common genetic cause of intellectual disability. 96% of Down syndrome cases are classic (regular) Down syndrome, 3-4% are translocation type and 1-2% are mosaic type. <1% of cases develop due to partial trisomy. The most important known risk factor for regular Down syndrome is advanced maternal age. Individuals with Down syndrome are at increased risk for have congenital heart disease, anal atresia, congenital hypothyroidism, Hashimoto's thyroiditis, Graves' disease, celiac disease, type 1 diabetes, atlantoaxial instability, joint laxity, feeding problems, hearing loss, otitis media, sleep apnea, vision problems, skin problems, transient abnormal myelopoiesis, acute myeloid leukemia, and acute lymphoblastic leukemia. In this study, 264 individuals with Down syndrome whose first application to our clinic were between 01.01.2010-31.12.2020 are included. Prenatal, natal, postnatal, medical and surgical treatment histories, demographic characteristics and clinical, laboratory and radiological findings were evaluated retrospectively. It was determined that 97% of individuals with Down syndrome had regular type, 2.3% had translocation type and 0.7% had mosaic type Down syndrome. Maternal age is 35 and over in 48.8% of individuals whose maternal age data are available. Congenital heart disease was detected in 71.8% of individuals with Down syndrome, with secundum ASD being the most common. Overt or subclinical hypothyroidism was found in 33.7% of individuals with Down syndrome, and it was observed that 82% of those with overt hypothyroidism had congenital hypothyroidism. It has been found that 14% of individuals with Down syndrome have hearing loss, which 77.7% of them are conductive hearing loss. A history of otitis media was found in 12.6% of individuals with Down syndrome. Sleep apnea was found in 95.6% of individuals with Down syndrome who underwent polysomnography. A correlation was found between the history of otitis media and sleep apnea. A history of recurrent pneumonia was found in 12.5% of individuals with Down syndrome, which correlates with congenital heart disease, high congenital heart disease class and immunologic parameter impairment. Transient abnormal myelopoiesis was seen in 6.1% of individuals with Down syndrome, acute lymphoblastic leukemia in 1.2% and acute myeloblastic leukemia in 1.6%.tr_TR
dc.language.isoturtr_TR
dc.publisherTıp Fakültesitr_TR
dc.rightsinfo:eu-repo/semantics/openAccesstr_TR
dc.subjectkonjenital kalp hastalığıtr_TR
dc.subject.lcshPediatritr_TR
dc.titleDown Sendromlu Bireylerin Klinik ve Laboratuvar Bulgularının Değerlendirilmesi, 11 Yıllık Tecrübetr_TR
dc.typeinfo:eu-repo/semantics/doctoralThesistr_TR
dc.description.ozetAlkan, D. Down Sendromlu Bireylerin Klinik ve Laboratuvar Bulgularının Değerlendirilmesi, 11 Yıllık Tecrübe, Hacettepe Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Uzmanlık Tezi, Ankara, 2022. Down sendromu toplumda 800 canlı doğumda bir görülür ve zihinsel yetersizliğin en sık genetik sebebidir. Down sendromu vakalarının %96’sı klasik (regüler) Down sendromuyken, %3-4’ü translokasyon tipi ve %1-2’si mozaik tiptir. Vakaların <%1’i parsiyel trizomiye bağlı gelişmektedir. Regüler Down sendromu için bilinen en önemli risk faktörü ileri anne yaşıdır. Down sendromlu bireyler konjenital kalp hastalıkları, anal atrezi, konjenital hipotiroidi, Hashimoto tiroiditi, Graves hastalığı, çölyak hastalığı, tip 1 diyabet, atlantoaksiyal instabilite, eklem laksisitesi, beslenme problemleri, işitme kaybı, otitis media, uyku apnesi, görme problemleri, cilt problemleri, geçici anormal miyelopoez, akut miyeloid lösemi ve akut lenfoblastik lösemi için artmış risk altındadırlar. Bu çalışmada kliniğimize ilk başvurusu 01.01.2010-31.12.2020 tarihleri arasında olan 264 Down sendromlu birey incelemeye alınmış bireylerin; prenatal, natal, postnatal, medikal ve cerrahi tedavi öyküleri, demografik özellikleri ve klinik, laboratuvar ve radyolojik bulguları retrospektif şekilde değerlendirilmiştir. Down sendromlu bireylerin %97’sinin regüler tip %2,3’ünün translokasyon tipi %0,7’sinin ise mozaik tip Down sendromu olduğu saptanmıştır. Anne yaşı verisine ulaşılan bireylerin %48,8’inde anne yaşı 35 ve üzerindedir. Down sendromlu bireylerin %71,8’inde konjenital kalp hastalığı saptanmış olup en sık olarak sekundum ASD görülmüştür. Down sendromlu bireylerin %33,7’sinde aşikar veya subklinik hipotiroidi saptanmış olup aşikar hipotiroidi saptananların %82’sinin konjenital hipotiroidi olduğu gözlenmiştir. Down sendromlu bireylerin %14’ünde işitme kaybı olduğu, bunların %77,7’sinin iletim tipi işitme kaybı olduğu anlaşılmıştır. Down sendromlu bireylerin %12,6’sında otitis media geçirme öyküsü saptanmıştır. Polisomnografi yapılan Down sendromlu bireylerin %95,6’sında uyku apnesi saptanmıştır. Otitis media öyküsü ile uyku apnesi arasında bir korelasyon olduğu saptanmıştır. Down sendromlu bireylerin %12,5’inde tekrarlayan pnömoni öyküsü saptanmış olup bu durumun konjenital kalp hastalığı, yüksek konjenital kalp hastalığı sınıfı ve immünolojik parametre bozukluğu ile korelasyon göstermektedir. Down sendromlu bireylerin %6,1’inde geçici anormal miyelopoez , %1,2’sinde akut lenfoblastik lösemi ve %1,6’sında akut miyeloblastik lösemi görülmüştür.tr_TR
dc.contributor.departmentÇocuk Sağlığı ve Hastalıklarıtr_TR
dc.embargo.termsAcik erisimtr_TR
dc.embargo.lift2023-03-08T08:47:51Z
dc.fundingYoktr_TR
dc.subtypemedicineThesistr_TR


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster